Vicore Pharma announces the Nomination Committee for the 2021 Annual General Meeting
Gothenburg, October 6, 2020 – Vicore Pharma Holding AB (publ) has appointed the Nomination Committee for the 2021 Annual General Meeting. The three largest shareholders as of August 31, 2020 have been offered to appoint a member to the Nomination Committee each, in accordance with the decision taken at the Annual General Meeting on May 20, 2020.The Nomination Committee consists of Staffan Lindstrand, appointed by HealthCap VII L.P., Evert Carlsson appointed by Swedbank Robur and Johannes Eckerstein, appointed by Protem Wessman. Vicore Pharma’s chairman, Michael Wolff Jensen, is also a